Gidel and Kocal Construction recently completed a new project in Brisbane, a multi-functional conversion of an office building which includes laboratories, clean rooms, tissue culture and support facilities. The space was completed for client Mammoth Biosciences.
The Mammoth Biosciences project, located at 1000 Marina Boulevard in Brisbane, Calif., was a collaborative effort between Gidel and Kocal, Mammoth Biosciences, and MA Architects. The result was a fully developed, two-floor, facility that also includes specialized lab rooms for specific projects, open-floor desk workrooms, comfortable lounge and cafeteria spaces, and meeting areas.
Upon completion of the multi-level build-out, Gidel and Kocal also supplied, installed, and commissioned all lab casework and fume hood as well as provided support for all Mammoth-supplied furniture, fixtures and equipment.
“The main goal for this project was an expedited tenant build out for a fast growing, innovative biotech company which was founded by some of the top scientists in the industry” said Steve Smith, senior project manager for Gidel and Kocal. “Gidel and Kocal had recently completed a complex office to life science building conversion for Phase-3 Development. When Mammoth Bioscience leased two complete floors to become their new headquarters, we worked closely with the design team, engineers, vendors and all involved to quickly obtain all departmental approvals and complete the project on time and well within budget.”
According to their website, Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. This is through the discovery and development of novel CRISPR (clustered regularly interspaced short palindromic repeats) systems. Mammoth hopes to provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more.
This past September, Mammoth announced that the company raised $195 million of financing at a valuation of more than $1 billion. The funding includes a $150 million Series D led by Redmile Group and a $45 million Series C, also led by Redmile Group and Foresite Capital, with participation from Sixth Street, Decheng Capital, Mayfield and Amazon, among others.
“The Mammoth Bioscience team is an extremely driven group of industry leading scientists that work non-stop to develop new products to benefit all of mankind and it was truly a pleasure to have the opportunity to be a part of that process” said Smith. “[They are] a very organized group of problem-solving professionals.”
As a company employing state-of-the-art technology to develop potentially useful contributions to the life-sciences industry, Mammoth required careful and deliberate considerations in order to make the space not only useful and comfortable, but also compliant with the work to be done on premises.
“One of [my] favorite features about the Mammoth Bioscience project is the very efficient design and overall layout that not only incorporates high-end biotech labs, clean rooms and related support areas, but also productive and people-friendly office, collaboration and break areas,” said Smith. “All materials and equipment utilized for this project were not only approved for life science type construction, but sustainability was also a key factor in all design considerations.”
The project, even though exciting, faced some challenges for the construction and design teams. One of those hurdles was Mammoth’s fast approaching need for new space.
“The project had to be completed on an expedited basis due to the fact that Mammoth had outgrown their existing facility and to help accommodate that, the project was completed in two phases” said Smith. “The first phase was completion of (an) approximately 12,000 square foot office area to provide workspace for several Mammoth teams, and the second phase was the R&D and production labs, clean rooms and support areas.”
Not only was timing an issue, but so were challenges related to the COVID-19 pandemic.
“There were all the challenges created by COVID and the related safety protocols and of course supply chain issues” said Smith.
However, teamwork between organizations was the best weapon against such obstacles. One such organization was Phase-3, a real estate company dedicated to the growth of the Life Science industry, and owners of the property at 1000 Marina Boulevard.
“All these (challenges) were effectively alleviated by close collaboration between Phase-3 , the design team, Mammoth and Gidel and Kocal,” said Smith. “Not only by the close collaboration and problem-solving approach by all involved, but I would add that Phase-3, who is a market leader in life science property development, takes a very proactive approach to making sure things get done and that their tenants reach their goals,” said Smith.
Perhaps the best news, however, was that Gidel and Kocal, even in the face of the previously-mentioned tough obstacles, were able to keep the overall cost of the project to respectable amounts.
“From a cost standpoint, we are proud to say that the project was completed at approximately 27 percent below industry standard for cost per square foot for similar life science type construction” said Smith.
Mammoth Biosciences, with approximately 90 employees, has relocated into the new space at 1000 Marina Boulevard. Because of the project’s timely completion, Mammoth was able to move in on schedule and continue experiencing its rapid growth.